drug
metreleptin
Phase 3updated 6mo agoby Amryt Pharma Plc
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying metreleptin
- phase3Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL
- —Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
- phase3Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
- —MEASuRE: Metreleptin Effectiveness And Safety Registry
- phase3Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
- phase4Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
- phase4Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
- phase2Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that